The No Surprises Act was designed to protect patients from unexpected medical bills, but a new investigation highlights a company's strategic use of its arbitration process.
This company appears to be profiting by navigating the complexities of the arbitration framework, raising questions about the efficacy and integrity of the Act's implementation.
The implications of this development could affect the overall capacity and throughput of healthcare services, as financial incentives may shift operational priorities.